Research status of lung transplantation and standardized management during transplantation period
- VernacularTitle:肺移植研究现状及移植期的规范化管理
- Author:
XU Longming
1
;
ZUO Yunxia
1
;
LIN Yidan
2
Author Information
1. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China
2. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China
- Publication Type:Journal Article
- Keywords:
Lung transplantation;
extracorporeal membraneoxygenation (ECMO);
donor lungs;
anesthetic management;
bridge of ECMO
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(02):209-213
- CountryChina
- Language:Chinese
-
Abstract:
Lung transplantation is the only treatment for patients with end-stage lung diseases. And this field is also a research hotspot in the international field at presen. Relevant researches not only promote the progress and development of lung transplantation, but also improve the life quality of patients after transplantation. With the development of lung transplantation technology, the guidelines for identifying candidates are constantly being revised, and the source of donor lungs has always been an urgent problem for all transplantation centers. The standardized management during transplantation period involves anesthesia induction, intraoperative fluid management, airway management, management of important operative steps and postoperative pain management. Extracorporeal life support (ECLS) includes cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO). With the progress and development of ECLS technology, the advantages of ECMO as a bridge for lung transplantation, intraoperative and postoperative circulatory support are becoming more and more prominent, enabling recipient patients to successfully pass the period of lung transplantation. Although lung transplantation in basic science and clinical researches has got a lot of progress, to improve the survival rate after transplantation, we must overcome many challenges including how to successfully perform lung transplantation, expand lung donor library, induce tolerance, and prevent complications after transplantation, primary graft dysfunction (PGD), cell and antibody mediated rejection and infection.
